Abstract
Within the last fifteen years, endovascular therapy has become the treatment of choice for complicated distal aortic dissection, distal arch repair and blunt thoracic aortic injuries. The identification and early detection of patients who are at risk of death or disease progression is a major part of aortic dissection management.
Even those with clinically silent uncomplicated distal dissection, long-term data suggest survival benefit from stent-induced remodelling of dissected aorta. Recent developments in the knowledge of factors predicting aortic expansion enable lesion-specific management tailored to the patient and aortic lesion.
Further work is required to identity the subgroup of patients who might be most likely to benefit from early endografting. (C) 2018 SOLEN s.r.o. All rights reserved.